National Vaccine
Information Center

Your Health. Your Family. Your Choice.

MedAlerts Home
Search Results

This is VAERS ID 275991

Case Details

VAERS ID: 275991 (history)  
Age: 19.0  
Gender: Female  
Location: Tennessee  
Vaccinated:0000-00-00
Onset:0000-00-00
Submitted: 2007-04-10
Entered: 2007-04-11
   Days after submission:1
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV4: HPV (GARDASIL) / MERCK & CO. INC. - / 1 UN / UN

Administered by: Other       Purchased by: Other
Symptoms: Cervical dysplasia, Colposcopy, Condition aggravated, Smear cervix abnormal
SMQs:, Reproductive premalignant disorders (narrow), Uterine and fallopian tube malignant tumours (broad)

Life Threatening? No
Died? No
Permanent Disability? No
Recovered? No
ER or Doctor Visit? Yes
Hospitalized? No
Previous Vaccinations:
Other Medications: Unknown
Current Illness: Sexually active; Cervical intraepithelial neoplasia II
Preexisting Conditions:
Diagnostic Lab Data: colposcopy, Pap test 12/??/06 - Results showed CIN 2 or 3
CDC Split Type: WAES0704USA00736

Write-up: Information has been received from a physician concerning a 19 year old female patient, sexually active for less than 1 year, who in December 2006 was vaccinated with a first dose of GARDASIL. A papanicolaou smear (PAP) test was done on the same day as the vaccination and the results showed cervical intraepithelial neoplasia (CIN) 2 or 3. After her second injection with GARDASIL vaccine (yeast) she required conization due to the rapid development of CIN. Human Papillomavirus (HPV) types were unknown. The physician felt that rapid development of CIN was an other important medical event. Additional information has been requested.


New Search

Link To This Search Result:

http://www.medalerts.org/vaersdb/findfield.php?IDNUMBER=275991


Copyright © 2017 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166